An exploratory study on prediction of risk for abemaciclib-induced interstitial lung disease or hepatotoxicity by specific human leukocyte antigen alleles.

Venetoclax, a pioneering B-cell lymphoma-2 (BCL-2) inhibitor, has transformed the therapeutic landscape for haematologic malignancies by restoring apoptosis in malignant cells. Its pharmacokinetic ...

Background. Posaconazole is a triazole with anti-Aspergillus activity. However, little is known about the utility of posaconazole as primary therapy for invasive pulmonary aspergillosis. Methods. An ...

SEATTLE--(BUSINESS WIRE)--Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to address central nervous system disorders, announced the publication of a manuscript ...